Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free OxyElite cases. Here at Leading Justice, we can personally customize your firm’s OxyElite advertising needs and help you sign up cases via internal cash buys. Our clients simply pay an agency fee to cover the cost of OxyElite advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. We also cross-qualify all of our contacts, meaning any data we generate that doesn’t qualify for the target campaign is reviewed to find out if it is eligible for another type of claim. By using proven approaches to target contacts specifically associated with liver injuries and OxyElite weight loss products, Leading Justice will increase your firm’s OxyElite caseload. If you are interested in helping victims of liver damage allegedly linked to recalled OxyElite dietary supplements, our vast consumer reach and direct advertising strategies give you the competitive edge and confidence you need to allocate your full budget, knowing that your money is being spent in the best way possible.
Every law firm we work with at Leading Justice plays an important role in determining how we classify claims as qualified or not. Our extensive experience working with plaintiff law firms allows us to recognize a great case when we see one, but we will also customize our OxyElite supplement case intake specifications to the exact criteria you are seeking. If your firm has certain OxyElite qualifying criteria you would like us to use, we will train our intake specialists to apply this criteria to each email and phone call they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of OxyElite data with zero chance of fraud.
Our Take on OxyElite Pro Dietary Supplements
OxyElite Pro dietary supplements manufactured by USPlabs were designed as an aid for individuals to lose weight and build muscle, but the products were recalled in late 2013, after the FDA found in September that a cluster of seven Hawaii residents who had consumed OxyElite Pro products developed acute liver failure and non-viral hepatitis. By the end of October 2013, 56 cases of acute liver failure or acute hepatitis associated with OxyElite Pro dietary supplements had been reported to the FDA, including one death and several cases where a liver transplant was necessary for survival. The FDA immediately issued a warning to drug maker USPlabs, urging the company to voluntarily recall the products or face legal action, and the OxyElite recall was announced in November 2013.
Federal officials are unsure why certain OxyElite weight loss products may put patients at risk for liver damage and other life-threatening injuries, but the FDA did note that the supplements contain a new dietary ingredient called aegeline, which has not been proven to be safe for human consumption. According to the FDA, drug firms are required to provide evidence of safety regarding new dietary ingredients 75 days before the product goes to market, but USPlabs failed to do so with its OxyElite products, putting consumers at unnecessary risk of serious and potentially fatal side effects. As more information comes to light about the link between OxyElite Pro dietary supplements and liver injury complications, consumers throughout the country are expected to pursue legal action against OxyElite maker USPlabs.